logo-loader
RNS
viewAvino

Antisoma plc - Antisoma to present at 11th Annual BIO CEO & Investor..

Conference in New York Antisoma to present at 11th Annual BIO CEO & Investor Conference in New York 3 February 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the 11th Annual BIO CEO & Investor Conference in New York on Monday, 9th February at 10:30am EST/3:30pm GMT. A webcast of the presentation will be available on Antisoma's website at http://www.antisoma.com/asm/media/webcast/ For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software. Enquiries: Daniel Elger VP, Marketing & Communications Antisoma plc +44 7909 915 068 Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma. ---END OF MESSAGE--- This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Quick facts: Avino

Price: -

Market: TSX-V
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS